Filing Details
- Accession Number:
- 0000899243-23-007218
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-06 19:01:00
- Reporting Period:
- 2023-03-02
- Accepted Time:
- 2023-03-06 19:01:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1792044 | Viatris Inc | VTRS | Pharmaceutical Preparations (2834) | 834364296 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1848812 | (Sean) Xiangyang Ni | 1000 Mylan Boulevard Canonsburg PA 15317 | President, Greater China | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-03-02 | 7,195 | $0.00 | 44,252 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-03-02 | 570 | $0.00 | 44,822 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-03-03 | 3,093 | $11.18 | 41,729 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-03-04 | 7,563 | $0.00 | 49,292 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-03-04 | 272 | $0.00 | 49,564 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-03-06 | 3,148 | $11.08 | 46,416 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2023-03-02 | 7,195 | $0.00 | 7,195 | $0.00 |
| Common Stock | Dividend Equivalent Units | Disposition | 2023-03-02 | 569 | $0.00 | 569 | $0.00 |
| Common Stock | Restricted Stock Units | Acquisiton | 2023-03-03 | 40,881 | $0.00 | 40,881 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2023-03-04 | 7,563 | $0.00 | 7,563 | $0.00 |
| Common Stock | Dividend Equivalent Units | Disposition | 2023-03-04 | 272 | $0.00 | 272 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 7,195 | No | 4 | M | Direct | ||
| 569 | No | 4 | M | Direct | ||
| 40,881 | No | 4 | A | Direct | ||
| 15,128 | No | 4 | M | Direct | ||
| 544 | No | 4 | M | Direct |
Footnotes
- Fractional shares have been rounded up in connection with the settlement described in footnote 9 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan.
- Shares sold to satisfy the tax liability associated with the vesting and settlement of the RSUs granted on March 2, 2021 and the related dividend equivalent units (DEUs).
- Represents the weighted average price of the reporting person's disposition of 3,093 shares of common stock in transactions ranging from $11.16 to $11.18. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock sold at each separate price within the range set forth in this footnote.
- Fractional shares have been rounded up in connection with the settlement described in footnote 13 pursuant to the terms of the RSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan.
- Shares sold to satisfy the tax liability associated with the vesting and settlement of the RSUs granted on March 4, 2022 and the related DEUs.
- Represents the weighted average price of the reporting person's disposition of 3,148 shares of common stock in transactions ranging from $10.995 to $11.14. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock sold at each separate price within the range set forth in this footnote.
- Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). 7,195 of the RSUs granted on March 2, 2021 vested on each of March 2, 2022 and March 2, 2023 and 7,195 will vest on March 2, 2024.
- On May 6, 2022, Viatris filed a registration statement on Form S-3 with respect to its Dividend Reinvestment and Share Purchase Plan; amount includes DEUs that subsequently accrued with respect to such RSUs in June 2022, September 2022 and December 2022 in transactions exempt from Section 16 under Rule 16a-11.
- Represents DEUs that accrued with respect to the RSUs previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs.
- Each RSU represents the right to receive one share of common stock of Viatris. The RSUs vest in three equal annual installments beginning on March 3, 2024.
- Each RSU represents the right to receive one share of common stock of Viatris. 7,563 of the RSUs granted on March 4, 2022 vested on March 4, 2023 and 7,564 will vest on each of March 4, 2024 and March 4, 2025.
- On May 6, 2022, Viatris filed a registration statement on Form S-3 with respect to its Dividend Reinvestment and Share Purchase Plan; amount represents DEUs that subsequently accrued with respect to such RSUs in June 2022, September 2022 and December 2022 in transactions exempt from Section 16 under Rule 16a-11.
- Represents DEUs that accrued with respect to the RSUs previously granted on March 4, 2022 and vest on the same schedule as the underlying RSUs.
Billionaire Hedge Funds
